India requires 75% local content in pharmaceuticals
The Indian government seeks to boost local drug production by stipulating that the ‘local content’ of domestic products is 75% and 10% for those that are non-domestic.
Archives for January 2, 2019
How in silico trials are making personalized medicine a reality
The biopharma industry is on the precipice of making personalized medicine a reality with access to massive amounts of data, computing power, and artificial intelligence to run in silico clinical trials, says GNS Healthcare CEO.
Almac expands neo-antigen peptide manufacturing
Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.
Light-sensitive labeling solutions allows for transparent packaging
Schreiner will provide three new UV protective labels, without sacrificing inspection ability for biologics and other light-sensitive products.